Investment thesis
Nestlé (NSRGY) is a very mature company that has reached a point where organic growth could be very limited, yet it will likely continue to grow slowly but steadily. The current focus in Nestlé Health Science shows how necessary it is for the company to expand beyond consumer staples in order to continue growing.
In January 2020, the company announced a CHF 20 billion share buyback program. Considering Nestlé's market cap is CHF ~300 billion, I expect a ~6.5% share reduction in the period 2020-2022. The current coronavirus crisis will boost Nestlé sales,